(Q33888153)

29 July 2017

1 reference

title

Effect of second-generation antipsychotics on cognition: current issues and future challenges (English)

1 reference

29 July 2017

S Kristian Hill

1

1 reference

29 July 2017

Jeffrey R Bishop

series ordinal

2

1 reference

29 July 2017

Donna Palumbo

series ordinal

3

1 reference

29 July 2017

John A Sweeney

series ordinal

4

1 reference

29 July 2017

1 January 2010

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

29 July 2017

1 reference

29 July 2017

10

1 reference

29 July 2017

1

1 reference

29 July 2017

43-57

1 reference

Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path-analytic approach for associations at baseline and following 24 weeks of antipsychotic drug therapy

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

A comparison of neuropsychological dysfunction in first-episode psychosis patients with unipolar depression, bipolar disorder, and schizophrenia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

An fMRI study of visual attention and sensorimotor function before and after antipsychotic treatment in first-episode schizophrenia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Pharmacological treatment effects on eye movement control

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

General and specific cognitive deficits in schizophrenia: Goliath defeats David?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Initial phase 2 trial of a nicotinic agonist in schizophrenia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Efficiency of the CATIE and BACS neuropsychological batteries in assessing cognitive effects of antipsychotic treatments in schizophrenia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Reduced attentional engagement contributes to deficits in prefrontal inhibitory control in schizophrenia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Oculomotor and neuropsychological effects of antipsychotic treatment for schizophrenia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

The neurobiology of cognition in schizophrenia.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Differential effects of haloperidol, clozapine and olanzapine on learning and memory functions in mice.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Targeting information-processing deficit in schizophrenia: a novel approach to psychotherapeutic drug discovery

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Iloperidone reduces sensorimotor gating deficits in pharmacological models, but not a developmental model, of disrupted prepulse inhibition in rats

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Cognitive rehabilitation for schizophrenia and the putative role of motivation and expectancies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

A comparison of cognitive structure in schizophrenia patients and healthy controls using confirmatory factor analysis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

The impact of atypical antipsychotic medications on long-term memory dysfunction in schizophrenia spectrum disorder: a quantitative review

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Neurotensin-deficient mice have deficits in prepulse inhibition: restoration by clozapine but not haloperidol, olanzapine, or quetiapine

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Cortical inhibitory neurons and schizophrenia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Mismatch negativity deficits are associated with poor functioning in schizophrenia patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Impact of atypical antipsychotics on quality of life in patients with schizophrenia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Bringing order to the glutamate chaos in schizophrenia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

The effects of atypical antipsychotic medications on psychosocial outcomes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Prefrontal neurons and the genetics of schizophrenia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Demonstrating specific cognitive deficits: a psychometric perspective

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Inhibition-based rhythms: experimental and mathematical observations on network dynamics

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

To model a psychiatric disorder in animals: schizophrenia as a reality test

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Psychomotor, Cognitive, extrapyramidal, and affective functions of healthy volunteers during treatment with an atypical (amisulpride) and a classic (haloperidol) antipsychotic

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

What are the functional consequences of neurocognitive deficits in schizophrenia?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Effects of clozapine on cognitive function in schizophrenia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Serum levels of anticholinergic drugs and impaired recent memory in chronic schizophrenic patients.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Memory deficits and anticholinergic levels in chronic schizophrenia.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Antipsychotic medication effects on neuropsychological functions

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

The measurement of differential deficit

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Antipsychotic drugs: clinical pharmacology and therapeutic use.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

The neuropsychological signature of schizophrenia: generalized or differential deficit?

28 July 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Neuropsychological course in the prodrome and first episode of psychosis: findings from the PRIME North America Double Blind Treatment Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Pretreatment and longitudinal studies of neuropsychological deficits in antipsychotic-naïve patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Procedural learning in schizophrenia after 6 months of double-blind treatment with olanzapine, risperidone, and haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Adverse effects of risperidone on spatial working memory in first-episode schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Olanzapine and risperidone block a high dose of methamphetamine-induced schizophrenia-like behavioral abnormalities and accompanied apoptosis in the medial prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Behavioral abnormality and pharmacologic response in social isolation-reared mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Chronic administration of clozapine alleviates reversal-learning impairment in isolation-reared rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Reversal of isolation-rearing-induced PPI deficits by an alpha7 nicotinic receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

The effects of chronic administration of quetiapine on the phencyclidine-induced reference memory impairment and decrease of Bcl-XL/Bax ratio in the posterior cingulate cortex in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

The effects of chronic administration of quetiapine on the methamphetamine-induced recognition memory impairment and dopaminergic terminal deficit in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Clozapine, SCH 23390 and alpha-flupenthixol but not haloperidol attenuate acute phencyclidine-induced disruption of conditional discrimination performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Quetiapine reverses the suppression of hippocampal neurogenesis caused by repeated restraint stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Olanzapine attenuates the okadaic acid-induced spatial memory impairment and hippocampal cell death in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

The effects of clozapine on delayed spatial alternation deficits in rats with hippocampal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Characterization of clozapine-induced changes in synaptic plasticity in the hippocampal-mPFC pathway of anesthetized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Clozapine normalizes prefrontal cortex dopamine transmission in monkeys subchronically exposed to phencyclidine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

N-desmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates N-methyl- d -aspartate receptor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Another view of therapy for cognition in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Long-term neurocognitive effects of olanzapine or low-dose haloperidol in first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Neurocognitive functioning in patients with first-episode schizophrenia : results of a prospective 5-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

A meta-analysis of cognitive change with haloperidol in clinical trials of atypical antipsychotics: dose effects and comparison to practice effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Longitudinal studies of antisaccades in antipsychotic-naive first-episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Impact of risperidone versus haloperidol on activities of daily living in the treatment of refractory schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Patient outcomes in schizophrenia II: the impact of cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Association of symptomatology and cognitive deficits to functional capacity in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Abbreviated neuropsychological assessment in schizophrenia: prediction of different aspects of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Neurophysiological biomarkers for drug development in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Neuropsychological dysfunction in antipsychotic-naive first-episode unipolar psychotic depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Abnormalities in visually guided saccades suggest corticofugal dysregulation in never-treated schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

Effects of risperidone on procedural learning in antipsychotic-naive first-episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.143

The effects of sub-chronic clozapine and haloperidol administration on isolation rearing induced changes in frontal cortical N-methyl-D-aspartate and D1 receptor binding in rats

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

The cost of schizophrenia: lessons from an international comparison.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Procedural learning in schizophrenia: further consideration on the deleterious effect of neuroleptics.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Longitudinal neuropsychological follow-up study of patients with first-episode schizophrenia.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Symptoms and cognition as predictors of community functioning: a prospective analysis.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Neurocognitive deficit in schizophrenia: a quantitative review of the evidence.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Does risperidone improve verbal working memory in treatment-resistant schizophrenia?

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Dopamine D2 receptor mechanisms contribute to age-related cognitive decline: the effects of quinpirole on memory and motor performance in monkeys.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879261

Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia

29 October 2018

1 reference

12 December 2020

Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation

1 reference

12 December 2020

Effects of clozapine on psychiatric symptoms, cognition, and functional outcome in schizophrenia

1 reference

12 December 2020

The cost of cognitive impairment in schizophrenia

1 reference

12 December 2020

Social functioning and neurocognitive deficits in outpatients with schizophrenia: a 2-year follow-up

1 reference

12 December 2020

Identifiers

DOI

10.1586/ERN.09.143

1 reference

29 July 2017

1 reference

29 July 2017

1 reference